Xtl Biopharmaceuticals annual total assets
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Xtl Biopharmaceuticals Total Assets Growth & History (XTLB)
Xtl Biopharmaceuticals's total assets was $166,000 for fiscal 2025.
View full Xtl Biopharmaceuticals company overviewXtl Biopharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $166,000 | −$8.4M | −98.06% |
| 2024 | 2024-12-31 | $8.6M | $6.1M | +252.43% |
| 2023 | 2023-12-31 | $2.4M | −$1.8M | −42.04% |
| 2022 | 2022-12-31 | $4.2M | −$2.4M | −36.75% |
| 2021 | 2021-12-31 | $6.6M | $115,000 | +1.77% |
| 2020 | 2020-12-31 | $6.5M | −$709,000 | −9.83% |
| 2019 | 2019-12-31 | $7.2M | −$1.4M | −15.90% |
| 2018 | 2018-12-31 | $8.6M | $2.0M | +30.20% |
| 2017 | 2017-12-31 | $6.6M | $3.6M | +118.30% |
| 2016 | 2016-12-31 | $3.0M | — | — |
Xtl Biopharmaceuticals quarterly total assets
Q4.16
Q4.17
Q4.18
Q4.19
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q4.23
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $166,000 | −$8.4M | −98.06% |
| Q2 2025 | 2025-06-30 | $714,000 | — | — |
| Q4 2024 | 2024-12-31 | $8.6M | $6.1M | +252.43% |
| Q4 2023 | 2023-12-31 | $2.4M | −$1.8M | −42.04% |
| Q4 2022 | 2022-12-31 | $4.2M | −$2.4M | −36.75% |
| Q2 2022 | 2022-06-30 | $5.8M | −$1.2M | −17.20% |
| Q4 2021 | 2021-12-31 | $6.6M | $115,000 | +1.77% |
| Q2 2021 | 2021-06-30 | $7.0M | — | — |
| Q4 2020 | 2020-12-31 | $6.5M | −$709,000 | −9.83% |
| Q4 2019 | 2019-12-31 | $7.2M | −$1.4M | −15.90% |
| Q4 2018 | 2018-12-31 | $8.6M | $2.0M | +30.20% |
| Q4 2017 | 2017-12-31 | $6.6M | $3.6M | +118.30% |
| Q4 2016 | 2016-12-31 | $3.0M | — | — |
Xtl Biopharmaceuticals total assets trends
Over the last five fiscal years, Xtl Biopharmaceuticals's total assets decreased from $6.5M to $166,000, a change of −$6.3M. The latest reported quarter, Q4 2025, shows $166,000.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xtl Biopharmaceuticals source filings ↗